U.S. FDA expected to authorize first COVID-19 vaccine for young children on Friday

October 29, 2021 admin Stock News 0

© Reuters. FILE PHOTO: FILE PHOTO: A woman holds a small bottle labelled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo

(Reuters) – The U.S. Food and Drug Administration is expected to authorize the Pfizer Inc (NYSE:) and BioNTech SE (NASDAQ:) coronavirus vaccine for children aged 5 to 11 years on Friday, the New York Times reported, citing people familiar with the agency’s planning.

The agency’s decision will make it the first COVID-19 shot for young children in the United States.

The decision is expected to make the vaccine available to 28 million children – many of whom are back in school for in-person learning – in the coming days. It comes after a panel of advisers to the FDA voted overwhelmingly to recommend the authorization on Tuesday.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*